Actos Bladder Cancer Lawsuits Grow

October 17, 2012 | Crandall & Pera Law
Actos Bladder Cancer Lawsuits Grow

Actos is a drug approved for proper use by the FDA however recent evidence indicates it can be extremely harmful to patients who use it.  As a result, there are many lawsuits being filed regarding the damages caused by this drug.

It was recently reported that over 115 Actos cases have been filed in Los Angeles alone:

The complaint against Actos manufacturer Takeda Pharmaceuticals and its subsidiaries (along with Eli Lilly, which collaborated with a Takeda subsidiary to market Actos) alleges that defendants knew or should have known that Actos was linked to bladder cancer in humans and had this knowledge for a over a decade and prior to filing its application in 1999.

Instead of warning plaintiffs, their physicians and the American public, Takeda and Eli Lilly “concealed and failed to completely disclose their knowledge that Actos was associated with or could cause bladder cancer or their knowledge that they had failed to fully study and test regarding that risk and, further, made conscious decisions to ignore the association between the use of Actos and pioglitazone hydrochloride and the risk of developing bladder cancer,” the complaint claims.

Read full coverage of the cases here...

If you or anyone you know has taken Actos and has damages you feel are due to this drug, please contact Steve Crandall for a full evaluation.